‘Breast Cancer Resistance Likelihood and Personalized Treatment Through Integrated Multiomics’

In recent times, enormous progress has been made in improving the diagnosis and therapeutic strategies for breast carcinoma, yet it remains the most prevalent cancer and second highest contributor to cancer-related deaths in women. Breast cancer (BC) affects one in eight females globally. In 2018 al...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehmood, Sabba, Faheem, Muhammad, Ismail, Hammad, Farhat, Syeda Mehpara, Ali, Mahwish, Younis, Sidra, Asghar, Muhammad Nadeem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048735/
https://www.ncbi.nlm.nih.gov/pubmed/35495618
http://dx.doi.org/10.3389/fmolb.2022.783494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048735/
https://www.ncbi.nlm.nih.gov/pubmed/35495618
http://dx.doi.org/10.3389/fmolb.2022.783494

Ejemplares similares